Skip to main content
VIYASH SCIENTIFIC LIMITED logo

VIYASH SCIENTIFIC LIMITED — Investor Relations & Filings

Ticker · VIYASH ISIN · INE807F01027 LEI · 335800SXM7D3VSHF2X07 BSE.NS Manufacturing
Open in API
Filings indexed 1,420 across all filing types
Latest filing 2026-05-19 Investor Presentation
Country IN India
Listing BSE.NS VIYASH

About VIYASH SCIENTIFIC LIMITED

https://www.viyash.com

Viyash Scientific Limited is an integrated pharmaceutical platform specializing in the development and manufacturing of Active Pharmaceutical Ingredients (APIs), advanced intermediates, and finished dosage forms. The organization operates a network of manufacturing facilities supported by robust research and development capabilities, focusing on complex chemistry and niche therapeutic segments. Its core business activities encompass the entire pharmaceutical value chain, from process development and scale-up to commercial-scale production. The company provides integrated solutions to global partners, leveraging its technical expertise in chemical synthesis and commitment to international quality standards. By maintaining a focus on operational excellence and innovation, the company serves as a strategic partner in the global healthcare supply chain, delivering high-quality medicinal components and formulations.

Recent filings

Filing Released Lang Actions
Investor Presentation
Investor Presentation Classification · 93% confidence The document is labeled and formatted as an ‘Investor Presentation for FY 2025-26’ in response to a SEBI Regulation 30 filing. It contains detailed slides on Q4/FY26 financial snapshots, performance highlights, business updates, merger synergy metrics, and forward-looking statements typical of a comprehensive investor deck rather than a simple earnings release or regulatory notice. Therefore, it matches the definition of an Investor Presentation (IP).
2026-05-19 English
Investor Presentation
Investor Presentation Classification · 94% confidence The document is labelled as "Investor Presentation for FY 2025-26" and contains slide‐style financial and strategic information (Q4/FY26 highlights, detailed consolidated P&L, business updates, merger synergies, etc.). It is a presentation deck provided under SEBI LODR Regulation 30, not merely an earnings snapshot and not the full statutory annual report. This matches the definition of an Investor Presentation (Code: IP).
2026-05-19 English
Press Release
Earnings Release Classification · 90% confidence The document is a press release announcing the audited standalone and consolidated Q4 FY25–26 financial results, complete with summary highlights (revenues, EBITDA, PAT) and an invitation to an earnings call. It does not contain the full financial statements (so it is not an Interim/Quarterly Report IR) but rather the initial announcement of periodical results, matching the definition of an Earnings Release. Q4 2026
2026-05-19 English
Press Release for the quarter and year March 31, 2026
Earnings Release Classification · 88% confidence The document is a press release announcing the audited standalone and consolidated financial results for Q4 and full year ended March 31, 2026, including key metrics (revenues, EBITDA, PAT) and an earnings call invitation. This matches an initial earnings release (ER) rather than a full interim report or other filing category. FY 2026
2026-05-19 English
Outcome of Board Meeting
Interim / Quarterly Report Classification · 78% confidence The document is a formal board meeting outcome notice to stock exchanges under SEBI LODR where the Board has approved and enclosed the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. It includes the full financial statements (balance sheet, P&L, cash flows) rather than just highlights and is filed as a periodic results announcement—not a full annual report, proxy statement, or mere dividend notice. This aligns with an Interim/Quarterly Report filing. FY 2026
2026-05-19 English
Outcome of Board Meeting
Earnings Release Classification · 85% confidence The document is a board meeting outcome notice to BSE and NSE under SEBI Listing Regulations, primarily announcing the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, and enclosing the full audited financial statements (balance sheet, P&L, cash flow) plus auditor’s report. This constitutes the company’s initial announcement of periodical financial results rather than the full statutory annual report. Therefore it best fits the Earnings Release category. FY 2026
2026-05-19 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.